Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

CVR Partners LP (UAN) Earnings: An Early Look

Earnings season is now starting to wind down, with most companies already having reported their quarterly results. But there are still some companies left to report, and CVR Partners LP (NYSE:UAN) is about to release its quarterly earnings report. The key to making smart investment decisions with stocks releasing their quarter reports is to anticipate how they’ll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you’ll be less likely to make an uninformed knee-jerk reaction to news that turns out to be exactly the wrong move.

CVR Partners LPThe fertilizer industry has been red-hot lately, and CVR Partners has benefited from trends that have given it a competitive advantage against some of its peers. But how long can the good times last? Let’s take an early look at what’s been happening with CVR Partners over the past quarter and what we’re likely to see in its quarterly report on Wednesday.

Stats on CVR Partners

Analyst EPS Estimate $0.18
Change From Year-Ago EPS (68%)
Revenue Estimate $54.35 million
Change From Year-Ago Revenue (38%)
Earnings Beats in Past 4 Quarters 3

Source: Yahoo! Finance.

Will CVR Partners help its unit price grow?
Analysts have had mixed views on CVR Partners lately. They’ve cut their fourth-quarter earnings estimates on the fertilizer master limited partnership in the past few months, but they’ve gotten more optimistic about its 2013 prospects, raising EPS estimates by $0.15. The partnership units, however, have gone nowhere, falling about 1% in price since mid-November.

CVR Partners is a rising player in the nitrogen fertilizer business, producing ammonia and urea ammonium nitrate fertilizer. By using petroleum coke as feedstock, most of which it obtains through a 20-year agreement with CVR Refining LP (NYSE:CVRR), CVR Partners has a locked-in source of raw materials to produce its fertilizers. With general partner CVR Energy, Inc. (NYSE:CVI) leading both CVR Partners and CVR Refining, the relationship among the three entities is well-supported.

With what amounts to a vertically integrated business, CVR Partners has some advantages over rivals Terra Nitrogen Company, L.P. (NYSE:TNH) and Rentech Nitrogen Partners LP (NYSE:RNF) . With low natural gas prices, Terra and Rentech haven’t had any trouble with their own production. But in the future, if nat-gas prices rise substantially above what CVR has to pay for petroleum coke, then CVR will gain a major margin advantage.

But last month, CVR gave investors some bad news by cutting its quarterly distribution by more than 60%. The company blamed scheduled plant maintenance activity during October as having greatly reduced its operations during the quarter, making it seem as though the drop would likely be temporary.

In its quarterly report, watch for early signs that this quarter has had CVR’s operations return to normal. If the company posts temporarily weak results, it could simply be a buying opportunity if CVR’s distribution ends up rising against next quarter.

The article CVR Partners Earnings: An Early Look originally appeared on and is written by Dan Caplinger.

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter @DanCaplinger. The Motley Fool has no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!